{"id":12176,"date":"2026-04-28T01:20:43","date_gmt":"2026-04-28T01:20:43","guid":{"rendered":"https:\/\/insightflowmedia.com\/?p=12176"},"modified":"2026-04-28T01:20:43","modified_gmt":"2026-04-28T01:20:43","slug":"clinical-presentation-and-manageme","status":"publish","type":"post","link":"https:\/\/insightflowmedia.com\/?p=12176","title":{"rendered":"Clinical Presentation and Manageme"},"content":{"rendered":"
\n
\n
\n
\n
\n

Patient presented with sudden painful erythematous lesions on the face and neck and was<\/p>\n

\n
<\/div>\n<\/div>\n

urgently referred to dermatology after initial clinical evaluation.<\/p>\n

Recent medication was discontinued due to suspected drug-related reaction.<\/p>\n

\n
<\/div>\n<\/div>\n

Workup included skin biopsy, complete blood count, and testing for antibodies, lupus anticoagulant, and serological markers.<\/p>\n

Oral corticosteroids were started for symptom control.<\/p>\n

Within 48 hours, lesions improved significantly and pain subsided.<\/p>\n

Laboratory results showed leukocytosis with neutrophilia, positive antibodies and lupus anticoagulant, while routine serology remained negative.<\/p>\n

Skin biopsy findings obtained later confirmed the diagnosis of Sweet syndrome.<\/p>\n

Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a rare inflammatory<\/p>\n

condition characterized by dense neutrophilic infiltration in the skin and sudden onset of painful erythematous papules or plaques.<\/p>\n

Its exact cause is unclear, but it is believed to involve cytokine-driven neutrophil activation.<\/p>\n

It is considered an immune-mediated hypersensitivity reaction associated with infections, malignancies, or drug exposure.<\/p>\n

Drug-induced cases are relatively common and may be linked to medications such as antibiotics, antiepileptics, contraceptives, antihypertensives, vaccines, and colony-stimulating factors.<\/p>\n

First-line treatment is oral corticosteroids, often producing rapid clinical improvement.<\/p>\n

Differential diagnosis includes urticaria, contact dermatitis, toxicoderma, and cutaneous lupus.<\/p>\n

Definitive diagnosis requires correlation of clinical presentation, laboratory findings, and histopathology to exclude systemic disease and guide appropriate therapy.<\/p>\n

\n
<\/div>\n<\/div>\n<\/div>\n